Dr. Stephen M. HahnVerified account

It is important that you keep doing what you are doing on behalf of the American people. Remember it is because of you that we are #FDAStrong. – Steve

To our FDA staff, thank you for your dedication and resilience – and for always keeping science as your North Star in everything you do. I will be cheering you on as you continue to carry out the mission of the FDA.

Through it all, FDA employees have been critical in helping to respond to this disease with scientific advances like the authorization of the 1st non-prescription OTC #COVID19 test, the authorization & approval of an antiviral agent, & the first two FDA-authorized COVID vaccines.

As a nation, and as a public health agency, we faced some big challenges and turbulent times over the past year, most notably those stemming from the #COVID19 pandemic.

These rules describe information that any company must provide if they seek to market a new tobacco product in this country, fulfilling the promise of the Tobacco Control Act.

The finalization of these rules is an important milestone in FDA’s regulation of tobacco products. The rules enable greater transparency & efficiency of FDA’s critical task of reviewing applications for tobacco products before new products can be sold in the U.S.

Through partnership between the FDA, members of Operation Warp Speed, @CDCgov, and @USDA, data from 21 FORWARD is also being made available to assist states with their planning efforts for vaccine distribution.

FDA is strongly committed to protecting public health based on good science. We’ve been open, transparent & believe these factors enhance America’s confidence in our independent judgements. We remain open to dialogues w/USG colleagues & all stakeholders on public health policies.

FDA believes it is essential that any potential changes to the current regulatory framework be informed by public feedback and capture the agencies’ distinct missions with respect to animal and human health.

FDA’s goal is to efficiently bring innovative products to market, while upholding our public health mandate & consumer confidence in product safety, as done in recent 1st in kind GalSafe pig approval. We’ll continue to work with developers to advance animal agricultural biotech.

It is essential to ensure that products are supported by the science, safe for the animal, safe for humans, and that it does what it claims to do. Ours is a long history of scientific expertise and decision-making on behalf of the American public.

FDA remains undeterred in our steadfast commitment to ensure that animal agricultural biotechnology products undergo independent and science and risk-based evaluation by our career experts.

FDA does not support the Memorandum of Understanding that @HHSGov signed with @USDA announced today. FDA has no intention of abdicating our public health mandate. We’ll continue to stay focused on executing our vital public health mission entrusted to us by the American people.

This is an opportune time to engage in a public discussion regarding FDA as an independent agency. We have learned that the public has greater confidence when there are assurances that FDA’s actions are based on clearly based on independent evaluations of data and science.